Establishment Labs Holdings Inc (ESTA) - Net Assets
Based on the latest financial reports, Establishment Labs Holdings Inc (ESTA) has net assets worth $14.78 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($351.04 Million) and total liabilities ($336.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ESTA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $14.78 Million |
| % of Total Assets | 4.21% |
| Annual Growth Rate | N/A |
| 5-Year Change | -53.59% |
| 10-Year Change | N/A |
| Growth Volatility | 102.36 |
Establishment Labs Holdings Inc - Net Assets Trend (2016–2025)
This chart illustrates how Establishment Labs Holdings Inc's net assets have evolved over time, based on quarterly financial data. Also explore Establishment Labs Holdings Inc asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Establishment Labs Holdings Inc (2016–2025)
The table below shows the annual net assets of Establishment Labs Holdings Inc from 2016 to 2025. For live valuation and market cap data, see ESTA market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $23.55 Million | -55.65% |
| 2024-12-31 | $53.09 Million | +188.64% |
| 2023-12-31 | $18.39 Million | +324.74% |
| 2022-12-31 | $-8.19 Million | -116.13% |
| 2021-12-31 | $50.74 Million | -32.31% |
| 2020-12-31 | $74.96 Million | +89.23% |
| 2019-12-31 | $39.61 Million | -42.99% |
| 2018-12-31 | $69.48 Million | +1486.10% |
| 2017-12-31 | $-5.01 Million | +81.04% |
| 2016-12-31 | $-26.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Establishment Labs Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 46277600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $433.38 Million | 1840.48% |
| Other Comprehensive Income | $1.16 Million | 4.91% |
| Other Components | $84.77 Million | 360.00% |
| Total Equity | $23.55 Million | 100.00% |
Establishment Labs Holdings Inc Competitors by Market Cap
The table below lists competitors of Establishment Labs Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Orbia Advance Corporation S.A.B. de C.V
F:4FZ
|
$2.11 Billion |
|
Hamilton Insurance Group, Ltd.
NYSE:HG
|
$2.11 Billion |
|
Banco do Nordeste do Brasil S.A
SA:BNBR3
|
$2.11 Billion |
|
TietoEVRY Corp
HE:TIETO
|
$2.11 Billion |
|
Klaviyo, Inc.
NYSE:KVYO
|
$2.10 Billion |
|
Nichidenbo Corp
TW:3090
|
$2.10 Billion |
|
Jenoptik AG
F:JEN
|
$2.10 Billion |
|
Viet Nam International Commercial Joint Stock Bank
VN:VIB
|
$2.10 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Establishment Labs Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 53,095,000 to 23,547,000, a change of -29,548,000 (-55.7%).
- Net loss of 51,064,000 reduced equity.
- Other comprehensive income decreased equity by 2,130,000.
- Other factors increased equity by 23,646,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-51.06 Million | -216.86% |
| Other Comprehensive Income | $-2.13 Million | -9.05% |
| Other Changes | $23.65 Million | +100.42% |
| Total Change | $- | -55.65% |
Book Value vs Market Value Analysis
This analysis compares Establishment Labs Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 91.38x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-1.43 | $72.64 | x |
| 2017-12-31 | $-0.27 | $72.64 | x |
| 2018-12-31 | $4.00 | $72.64 | x |
| 2019-12-31 | $1.93 | $72.64 | x |
| 2020-12-31 | $3.21 | $72.64 | x |
| 2021-12-31 | $2.12 | $72.64 | x |
| 2022-12-31 | $-0.33 | $72.64 | x |
| 2023-12-31 | $0.72 | $72.64 | x |
| 2024-12-31 | $1.89 | $72.64 | x |
| 2025-12-31 | $0.79 | $72.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Establishment Labs Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -216.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -24.19%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 15.17x
- Recent ROE (-216.86%) is below the historical average (-106.15%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -111.91% | 0.67x | 0.00x | $-19.52 Million |
| 2017 | 0.00% | -100.62% | 0.61x | 0.00x | $-34.40 Million |
| 2018 | -30.36% | -34.47% | 0.53x | 1.68x | $-28.05 Million |
| 2019 | -96.30% | -42.59% | 0.77x | 2.94x | $-42.11 Million |
| 2020 | -50.85% | -45.02% | 0.54x | 2.09x | $-45.62 Million |
| 2021 | -81.08% | -32.47% | 0.91x | 2.75x | $-46.21 Million |
| 2022 | 0.00% | -46.51% | 0.77x | 0.00x | $-74.39 Million |
| 2023 | -426.76% | -47.53% | 0.61x | 14.60x | $-80.34 Million |
| 2024 | -159.33% | -50.95% | 0.48x | 6.53x | $-89.91 Million |
| 2025 | -216.86% | -24.19% | 0.59x | 15.17x | $-53.42 Million |
Industry Comparison
This section compares Establishment Labs Holdings Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,807,561,702
- Average return on equity (ROE) among peers: -107.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Establishment Labs Holdings Inc (ESTA) | $14.78 Million | 0.00% | 22.75x | $2.10 Billion |
| Abbott Laboratories (ABT) | $17.48 Billion | 27.92% | 1.43x | $150.71 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $12.40 Million | -202.26% | 2.49x | $16.66 Million |
| Aethlon Medical Inc (AEMD) | $-2.20 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $-879.00K | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $10.55 Million |
| Allurion Technologies, Inc. (ALUR) | $19.83K | -26.07% | 15.64x | $9.21 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $1.96 Million | -680.21% | 0.05x | $3.99 Million |
| Artivion Inc (AORT) | $285.70 Million | 0.60% | 1.12x | $1.13 Billion |
| Apyx Medical Inc (APYX) | $14.83 Million | -75.59% | 3.51x | $153.68 Million |
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more